Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : AAV00531Z
Serotype : AAV Serotype 9 Storage : -80 ℃
Titer: Size:
| Cat. No. | AAV00531Z |
| Description | AAV serotype 9 particles express 2A-linked NanoLuc Luciferase and mCherry reporter genes under the control of CAG promoter for neuronal specific expression. |
| Gene | NLuc-2A-mCherry |
| Serotype | AAV Serotype 9 |
| Reporter | mCherry, NLuc |
| Applications |
1. Determination of optimal MOI (multiplicity of infection), administration methods etc. 2. Detection of the infection efficiency of the AAV serotype against a specific cell type or tissue. 3. Using reporter genes to visualize the distribution and expression of AAV vectors in live animals, helping assess the biodistribution and persistence of gene delivery. |
| Titer | Varies lot by lot, typically ≥1x10^12 GC/mL |
| Size | Varies lot by lot, for example, 30 μL, 100 μL, 500 μL etc. |
| Storage | Store at -80℃. Avoid multiple freeze/thaw cycles. |
| Shipping | Frozen on dry ice |
| Summary | Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots. |
| Endotoxin | Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance. |
| Purity | AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE. |
| Sterility | The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth. |
| Transducibility | Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities. |
| Empty vs. Full Capsids | Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods. |
AAV9-CAG-NLuc-2A-mCherry is a viral vector system that combines multiple advantages, making it particularly suitable for neuroscience research. This AAV serotype 9 vector exhibits excellent tropism for neuronal cells, enabling efficient transduction throughout the nervous system, including across the blood-brain barrier. The CAG hybrid promoter drives strong and sustained expression of dual reporter genes (NanoLuc luciferase and mCherry), while maintaining neuronal specificity. The inclusion of a 2A self-cleaving peptide ensures equimolar co-expression of both reporter genes without affecting the function of either protein. NanoLuc luciferase provides an extremely bright bioluminescent signal (100 times brighter than firefly luciferase), offering high sensitivity for quantitative analysis; while mCherry provides intuitive visual tracking and excellent photostability.
The AAV9-CAG-NLuc-2A-mCherry system has broad applications in neuroscience research and therapeutic development. It enables precise monitoring of neuronal activity patterns through bimodal imaging—combining sensitive bioluminescent detection and spatial fluorescent localization. Researchers utilize this vector construct to map neural circuits, track axonal transport, and study synaptic connections in vivo. The system is particularly valuable for longitudinal studies requiring repeated measurements, as the stability of NanoLuc allows for reliable signal detection over extended periods. In disease modeling, it aids in studying neurodegenerative processes, providing insights into disease mechanisms by correlating functional changes (via luciferase activity) and morphological changes (via mCherry fluorescence). This vector is an excellent platform for testing gene therapy approaches, with the reporter genes used to quantitatively assess transduction efficiency and transgene expression levels. Furthermore, the high brightness of the reporter genes makes high-throughput screening of neuroactive compounds in primary neuronal cultures possible.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
From inquiry to delivery, Creative Biogene's customer service was top-notch. Their team was knowledgeable, responsive, and ensured that our AAV9 vector met all of our research requirements.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.